Table 1: Clinicopathological data for nonmucinous EOC cohort ( ).

VariableNumber%

Age at diagnosis
 >609756.4
 <607343.6
FIGO stage
 I3218.6
 II179.9
 III7241.9
 IV4325.0
 NA 84.6
TNM-T
 13218.6
 22112.2
 310762.2
 4 74.1
 NA 52.9
TNM-N
 09655.8
 14123.8
 NA3520.4
TNM-M
 010158.7
 14526.2
 NA2615.1
Grade
 1158.7
 25833.7
 39857.0
 NA 10.6
Histological type
 Serous (SOC)8448.8
 Endometrioid (EnOC)3922.7
 Clear cell (ClCOC)4224.4
 Transitional cell (TCOC) 74.1
Ascites at primary diagnosis
 Yes8951.7
 No8348.3
Residual disease
 ≥10 mm8448.8
 ≤10 mm4928.5
 NA3222.7
Primary cancer origin
 Both ovaries8046.5
 Left ovary4325.0
 Right ovary4023.2
 NA 95.3
Performance status
 Healthy7744.8
 Systematic disease5531.9
 Severely sick 10.6
 NA3922.7
With cancer family history CA125 (preoperative)
 Yes4023.3
 ≥35 U/mL7543.6
 ≤35 U/mL105.8
 NA8750.6
Relapse
 Yes14081.4
 No3218.6
Platinum chemotherapy
 Sensitive4526.2
 Resistant9354.0
 NA3419.8
Outcome
 Death related to malignancy8851.2
 Unrelated, no disease 10.6
 NA8348.2
Progressive disease (months)
 Yes3620.9
 No13679.1